Metabolic syndrome components as markers to prognosticate the risk of developing chronic kidney disease: Evidence-based study with 6492 individuals

Journal of Epidemiology and Community Health

Volumn 69, Issue 6, 2015, Pages 594-598

  Zomorrodian, Davoud ^a   Khajavi Rad, Abolfazl ^a,b   Avan, Amir ^a,c   Ebrahimi, Mahmoud ^d   Nematy, Mohsen ^a   Azarpazhooh, Mahmoud Reza ^d   Emamian, Marzieh ^a   Sadeghzade, Mahsa ^a   Mirhafez, Seyed Reza ^a   Mohammadi, Maryam ^a   Mousavi, Mina ^a   Esmaeili, Habibollah ^a   Moohebati, Mohsen ^d   Parizadeh, Mohammad Reza ^a   Ferns, Gordon A ^e   Ghayour Mobarhan, Majid ^a,d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKER; CARDIOVASCULAR DISEASE; DISEASE PREVALENCE; HEALTH RISK; METABOLISM; MULTIVARIATE ANALYSIS; PUBLIC HEALTH; RESEARCH METHOD;

BIOLOGICAL MARKER; CREATININE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGE DISTRIBUTION; BLOOD; CASE CONTROL STUDY; COMORBIDITY; DISEASE COURSE; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SEX RATIO; STATISTICAL MODEL; UREA NITROGEN BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGE DISTRIBUTION; BIOMARKERS; BLOOD UREA NITROGEN; CASE-CONTROL STUDIES; COMORBIDITY; CREATININE; DISEASE PROGRESSION; EARLY DIAGNOSIS; EVIDENCE-BASED MEDICINE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IRAN; LIPOPROTEINS, HDL; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SEX DISTRIBUTION; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84955198365     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2014-205160     Document Type: Article

References (19)

1. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005;16:180-8.
2. Eknoyan G, Lameire N, Barsoum R, et al. The burden of kidney disease: improving global outcomes. Kidney Int 2004;66:1310-14.
3. El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005;365(9456):331-40.
4. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. NEJM 2004;351:1296-305.
5. Tanaka H, Shiohira Y, Uezu Y, et al. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006;69:369-74.
6. Alberti K, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
7. Chen J, Gu D, Chen CS, et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 2007;22:1100-6.
8. Agarwal S, Shlipak MG, Kramer H, et al. The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis. Cardiol Res Pract 2012;2012:806102.
9. Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005;365:1398-405.
10. Kitiyakara C, Yamwong S, Cheepudomwit S, et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 2007;71:693-700.
11. Poudel B, Gyawali P, Yadav BK, et al. Prevalence of metabolic syndrome in chronic kidney disease: a hospital based cross-sectional study. J Nepal Health Res Counc 2013;11:208-11.
12. Mirhafez SR, Mohebati M, Feiz Disfani M, et al. An imbalance in serum concentrations of inflammatory and anti-inflammatory cytokines in hypertension. J Am Soc Hypertens 2014;8:614-23.
13. Ninomiya T, Kiyohara Y, Kubo M, et al. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis 2006;48:383-91.
14. Tozawa M, Iseki K, Iseki C, et al. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int 2002;62:1743-9.
15. Muntner P, Coresh J, Smith JC, et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000;58:293-301.
16. Chonchol M, Shlipak MG, Katz R, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 2007;50:239-47.
17. Weiner DE, Tighiouart H, Elsayed EF, et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008;19:1204-11.
18. Suliman ME, Johnson RJ, García-López E, et al. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis 2006;48:761-71.
19. Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008;19:2407-13.